Nektar Therapeutics
NKTR
#4560
Rank
C$3.01 B
Marketcap
C$105.02
Share price
5.23%
Change (1 day)
665.40%
Change (1 year)

EPS for Nektar Therapeutics (NKTR)

EPS in 2025 (TTM): C-$5.94

According to Nektar Therapeutics 's latest financial reports the company's current EPS (TTM) is C-$5.87. In 2024 the company made an earnings per share (EPS) of C-$4.85 an increase over its 2023 EPS that were of C-$30.38.

EPS history for Nektar Therapeutics from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C-$5.9422.45%
2024C-$4.85-84.02%
2023C-$30.38-25.89%
2022C-$40.99-31.12%
2021C-$59.5114.86%
2020C-$51.81-1.19%
2019C-$52.43-163.96%
2018C$81.98-725.4%
2017C-$13.11-42.73%
2016C-$22.8983.33%
2015C-$12.4839.53%
2014C-$8.95-69.29%
2013C-$29.13-6.67%
2012C-$31.21

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$15.45-363.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$1.89-132.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$19.88-438.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
C-$2.57-56.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$10.14-272.82%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$8.23-240.19%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
C$0.09710-101.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
C$2.87-148.94%๐Ÿ‡ฎ๐Ÿ‡ช Ireland